SCHEMBL7055800

SCHEMBL7055800

COc1ccc(C2CC=CC(=O)C2)cc1OC

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 15/20 0.56
PDE4B Q07343 11/20 0.56
PDE4C Q08493 11/20 0.56
PDE4D Q08499 11/20 0.56
NR3C1 P04150 1/20 0.49
TSHR P16473 1/20 0.45
CASP1 P29466 1/20 0.45
GAA P10253 1/20 0.45
RAB9A P51151 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
GFER P55789 1/20 0.44
VEGFA P15692 1/20 0.44
ALDH1A1 P00352 1/20 0.44
LMNA P02545 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
MAPT P10636 1/20 0.44
CYP2C9 P11712 1/20 0.44
ALOX15 P16050 1/20 0.44
CREBBP Q92793 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL426375 0.78 PDE4A (0.64) PDE4APDE4BPDE4CPDE4DNR3C1
SCHEMBL7054809 0.76 PDE4A (0.60) PDE4APDE4BPDE4CPDE4DNR3C1
SCHEMBL2471687 0.74 PDE4A (0.59) PDE4APDE4BPDE4CPDE4DNR3C1
SCHEMBL14492203 0.74 PDE4A (0.72) PDE4APDE4BPDE4CPDE4DGFER
SCHEMBL1494013 0.74 NR3C1 (0.64) PDE4APDE4BPDE4CPDE4DNR3C1
SCHEMBL34463204 0.73 MAP1LC3B (0.50) ALDH1A1LMNAMAPT
SCHEMBL3536936 0.72 PDE4A (0.76) PDE4APDE4BPDE4CPDE4DNR3C1
Ammonia Solution, Strong SCHEMBL7288975 0.72 NR3C1 (0.62) PDE4APDE4BPDE4CPDE4DNR3C1
SCHEMBL7293719 0.72 PDE4A (1.00) PDE4APDE4BPDE4CPDE4DVEGFA
SCHEMBL7052450 0.72 PDE4A (0.71) PDE4APDE4BPDE4CPDE4DNR3C1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0940387-B1 PHENYLETHANOLAMINE COMPOUNDS USEFUL AS BETA3 AGONIST, PROCESS FOR PRODUCING THE SAME, AND INTERMEDIATES IN THE PRODUCTION OF THE SAME MITSUBISHI PHARMA CORP (JP) 2003-05-07 EP disclosed
US-6069176-A PHENYLETHANOLAMINE COMPOUNDS WITH A BETA-3 ADRENERGIC RECEPTOR STIMULATING EFFECT, USE AS A THERAPY FOR URINARY INCONTINENCE MITSUBISHI-TOKYO PHARMACEUTICALS, INC. (JP) 2000-05-30 US disclosed
EP-0940387-A1 PHENYLETHANOLAMINE COMPOUNDS USEFUL AS BETA3 AGONIST, PROCESS FOR PRODUCING THE SAME, AND INTERMEDIATES IN THE PRODUCTION OF THE SAME TOKYO TANABE COMPANY LIMITED (JP) 1999-09-08 EP disclosed